Beth Y. Karlan

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1

  Current Oncology · 2025-12-15 · 2 citations

• Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in <i>BRCA1</i> or <i>BRCA2</i>

  JNCI Journal of the National Cancer Institute · 2025-12-13 · 2 citations

• Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort

  Current Oncology · 2025-12-01

• From the ground up: Launching <scp>GENETECA</scp> ™ ( <scp>GENetic</scp> education and <scp>TEsting</scp> for <scp>CAncer</scp> ) a point‐of‐care cancer genetics service at an academic medical center

  Journal of Genetic Counseling · 2025-11-28

• Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

  2025-11-25

• Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

  npj Genomic Medicine · 2025-11-20

• Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study

  BMC Cancer · 2025-11-10

• Immunocompetent C57BL/6 syngeneic mouse ovarian cancer models with defined genetic alterations

  Scientific Reports · 2025-10-07 · 1 citations

• Cancer Growth and Invasion Are Increased in the Tight Skin (TSK) Mouse

  Cancers · 2025-09-09

• Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

  Gynecologic Oncology · 2025-06-05 · 2 citations

• The mutational landscape defines the proteome and spatial organization of tumor, stroma and immune cells in ovarian cancerPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-06-03 · 1 citations

• The impacts of the <i>Dobbs</i> ruling on US cancer care delivery

  JNCI Journal of the National Cancer Institute · 2025-05-20 · 4 citations